Latest Insider Transactions at Fennec Pharmaceuticals Inc. (FENC)
This section provides a real-time view of insider transactions for Fennec Pharmaceuticals Inc. (FENC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FENNEC PHARMACEUTICALS INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FENNEC PHARMACEUTICALS INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
SELL
Sale (or disposition) back to the issuer
|
Direct |
19,052
-9.99%
|
$152,416
$8.54 P/Share
|
|
Sep 21
2022
|
Robert Andrade CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+16.43%
|
-
|
|
Jul 18
2022
|
Chris A Rallis |
SELL
Payment of exercise price or tax liability
|
Direct |
4,379
-13.67%
|
$26,274
$6.7 P/Share
|
|
Jul 18
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
11,111
+25.75%
|
$0
$0.45 P/Share
|
|
Mar 08
2022
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
17,592
+36.17%
|
$0
$0.57 P/Share
|
|
Oct 21
2021
|
Chris A Rallis |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+50.0%
|
$3,333
$1.5 P/Share
|
|
May 04
2020
|
Southpoint Capital Advisors LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
80,000
+1.92%
|
$480,000
$6.25 P/Share
|